Antibody theranostics in precision medicine
- PMID: 36724783
- DOI: 10.1016/j.medj.2023.01.001
Antibody theranostics in precision medicine
Abstract
With the increasing use of antibody therapeutics, clinicians are faced with challenges of precisely stratifying patients and promptly assessing response to treatment. Antibody theranostics combines the advantages of radionuclides and antibodies (or antibody derivatives) to systematically integrate targeted diagnostics and therapeutics and will play important roles in precision medicine.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests W.W. is a consultant of Alpha Nuclide (Ningbo) Medical Technology Co., Ltd.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
